You are here

Effect Of Meloxicam Versus Placebo In Mainland Chinese Patients With Osteoarthritis Of The Knee

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Hefei, Anhui, 230001 China
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Osteoarthritis of the Knee
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-75 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Subjects are required to meet the following criteria to be eligible for Randomization into
this study:

- Male or female Chinese subjects, 18-75 years of age;

- Subjects must have a diagnosis of OA of the index knee based on American College of
Rheumatology criteria with X ray confirmation (a Kellgren Lawrence x ray grade of
greater than or equal to 2) (Kellgren J. & Lawrence J, 1957)

- Subjects must have have an NRS and a WOMAC pain sub scale score of 4 at Screening and
at Baseline based on four daily diary entries

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

Subjects presenting with any of the following will not be included in the study:

- History of other disease that may involve the index (painful) knee including
inflammatory joint diseases or have had recent surgical intervention on the knee.

- Diagnosed as having or has been treated for esophageal, gastric, pyloric channel, or
duodenal ulceration within 30 days prior to receiving the first dose of study
medication. History of or active gastrointestinal disease (eg, inflammatory bowel
disease), a chronic or acute renal or hepatic disorder, or a significant coagulation
defect.

- Signs and symptoms of clinically significant cardiac disease

NCT01430559
Pfizer
Completed
Effect Of Meloxicam Versus Placebo In Mainland Chinese Patients With Osteoarthritis Of The Knee

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now